Product NewsThe German National Center for Tumor Diseases (NCT) Heidelberg and Protagen AG Investigate Responsiveness to Checkpoint Inhibitors in Melanoma
Product NewsProtagen Signs Collaboration with QIAGEN to Develop Novel Protein-Based Companion Diagnostics for Autoimmune Therapies
Industry NewsProtagen Selected by Pfizer to Support Clinical Drug Development of a Novel Compound in Autoimmune Diseases
